Amylyx Pharmaceuticals
AMLX
$2.03
Share price
1.50%
Change (1 day)
-92.68%
Change (1 year)
Categories
Amylyx Pharmaceuticals (AMLX) - Cash on Hand
Cash on Hand as of December 2023 : $0.37 B
According to Amylyx Pharmaceuticals's latest financial reports the company has $0.37 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Amylyx Pharmaceuticals - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.37 B | 7.04% |
| 2022-12-31 | $0.34 B | 260.96% |
| 2021-12-31 | $96.11 M | 646.43% |
| 2020-12-31 | $12.87 M | 320.13% |
| 2019-12-31 | $3.06 M |